newsfilter
← Latest News
GlobeNewswire·

Homology Medicines Reports Third Quarter 2021 Financial Results and Recent Highlights

- Achieved Goal of Three Clinical Programs Across Gene Therapy and Gene Editing Technology Platform This Year - - Start of First Gene Editing Trial Advances Mission to Develop Solutions for Both Adults and Pediatric Patients with PKU - - Initiated